Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

A Trial to Evaluate the Safety and Efficacy of Elamipretide in Subjects With Primary Mitochondrial Myopathy Followed by an Open-Label Extension (MMPOWER-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03323749
Recruitment Status : Active, not recruiting
First Posted : October 27, 2017
Last Update Posted : January 28, 2020
Information provided by (Responsible Party):
Stealth BioTherapeutics Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 20, 2019
Estimated Study Completion Date : August 2022